Literature DB >> 18292935

Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.

Nektaria Simiantonaki1, Caren Jayasinghe, Romi Michel-Schmidt, Kirsten Peters, Maria Iris Hermanns, Charles James Kirkpatrick.   

Abstract

Adaptation to hypoxia, a universal hallmark of carcinomas, is a critical step for tumor cell survival and growth. One of the principal regulators of hypoxia-responsive pathways is the transcription factor hypoxia-inducible factor-1 alpha (HIF-1 alpha). Currently, it is known that tumoral production of members of the vascular endothelial growth factor (VEGF)-family (VEGFs) may promote tumor growth and progression by acting on carcinoma cells that express the cognate receptors (VEGFRs). However, the influence of hypoxia in the formation of such a tumoral VEGF/VEGFR loop is not completely understood. In the present study we examined the potential existence of a HIF-1 alpha/VEGF/VEGFR autocrine loop on commonly occurring carcinomas. The experiments were performed on five colorectal carcinoma cell lines, one breast (MCF7) and one lung (A549) adenocarcinoma cell line under normoxic and oxygen stress conditions using HIF-1 alpha-EIA, VEGFs-ELISA as well as RT-PCR and immunofluorescence for VEGFRs. HIF-1 alpha overexpression was found already after 2 h of exposure to hypoxia in all above mentioned cell lines, thus documenting that activation of the transcription factor HIF-1 alpha is an early cellular event. Under hypoxic conditions a significant upregulation and activation of HIF-1 alpha accompanied by an increased production of VEGF in MCF7 and A549 was observed. The well-differentiated colorectal carcinoma cell lines were 'hypoxia-resistant' showing unchanged levels of HIF-1 alpha and VEGF under hypoxia. None of the cell lines used in this study expressed the VEGF receptors VEGFR-1 and VEGFR-2 under normoxia and hypoxia. Additionally, all colorectal carcinoma cell lines were negative for VEGFR-3 transcripts in both conditions. However, VEGFR-3 mRNA and protein were expressed and under hypoxia overexpressed in MCF7 and A549. Hypoxic cultures of both cell lines secreted in elevated levels the VEGFR-3 ligand VEGF-C but not VEGF-D. Our findings suggest that under hypoxic conditions an autocrine loop between VEGF-C/VEGFR-3 and HIF-1 alpha is possible in breast carcinoma and lung carcinoma but not in colorectal carcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292935

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  26 in total

1.  D2-40/podoplanin expression in the human placenta.

Authors:  Y Wang; J Sun; Y Gu; S Zhao; L J Groome; J S Alexander
Journal:  Placenta       Date:  2010-11-20       Impact factor: 3.481

2.  E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.

Authors:  David Engelmann; Deborah Mayoli-Nüssle; Christian Mayrhofer; Katharina Fürst; Vijay Alla; Anja Stoll; Alf Spitschak; Kerstin Abshagen; Brigitte Vollmar; Sophia Ran; Brigitte M Pützer
Journal:  J Mol Cell Biol       Date:  2013-09-06       Impact factor: 6.216

3.  Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer.

Authors:  Bin Du; Zhen-Yu Yang; Xue-Yun Zhong; Mao Fang; Yong-Rong Yan; Guo-Long Qi; Yun-Long Pan; Xu-Long Zhou
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

4.  Model of vascular desmoplastic multispecies tumor growth.

Authors:  Chin F Ng; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2017-05-18       Impact factor: 2.691

5.  Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Sasidharan Padmaja Divya; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Donghern Kim; Jin Dai; Padmaja Asha; Zhuo Zhang; Yitao Wang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-23       Impact factor: 4.219

6.  Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.

Authors:  Francesca Spinella; Valentina Caprara; Valeriana Di Castro; Laura Rosanò; Roberta Cianfrocca; Pier Giorgio Natali; Anna Bagnato
Journal:  J Mol Med (Berl)       Date:  2012-09-11       Impact factor: 4.599

7.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

8.  Rac1 activates HIF-1 in retinal pigment epithelium cells under hypoxia.

Authors:  Peng Zhang; Xing Zhang; Xiaofeng Hao; Yusheng Wang; Yannian Hui; Haiyan Wang; Dan Hu; Jian Zhou
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-23       Impact factor: 3.117

9.  Combining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancer.

Authors:  Jill M Siegfried; Christopher T Gubish; Mary E Rothstein; Cassandra Henry; Laura P Stabile
Journal:  J Thorac Oncol       Date:  2012-03       Impact factor: 15.609

10.  Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.

Authors:  H Jia; L Cheng; M Tickner; A Bagherzadeh; D Selwood; I Zachary
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.